Want it in your inbox every Friday?
Sign up here.
Money attracts money, as the saying goes.
This week seemed to confirm it, with a couple startups announcing new rounds of funding only months after their previous ones, and familiar names launching new ventures.
Image Credits: Romain Dillet / TechCrunch
Whether it’s about IPOs, lobbying, or launching in public, finding momentum is key to success.
Confetti time:
- Salva Health: won the Startup Battlefield competition at TechCrunch Disrupt 2024 with the promise to lower breast cancer mortality thanks to an affordable screening device.
- The four other finalists out of the initial 200 shortlist were:
- Gecko Materials
- Luna
- MabLab
- Stitch3D
Half Zomato:
India’s largest food delivery and quick-commerce scale-up Swiggy is looking to go public at a $11.3 billion value, less than half the market cap of its rival Zomato.
Wait and see:
Nasdaq CEO Adena Friedman declared that she wasn’t surprised that we haven’t seen a resurgence in startup IPOs yet. However, she thinks these will start to return with momentum in 2025.
EU Inc momentum:
A petition calling for a new legal form for European startups is gaining momentum, with hopes of fostering Pan-European tech champions, but there are many hurdles to overcome along the way.
Eaten up:
Generative AI unicorn ElevenLab hired the team behind open source read-it-later app Omnivore. The team will now focus on ElevenReader, ElevenLabs’ own reader app.
Image Credits: Marlena Sloss/Bloomberg and Ramin Talaie/Getty Images (composite) / Getty Images
If the names below sound familiar, it’s because several of these startups raised their previous rounds quite recently.
Chatbots:
- Sierra: an AI customer service startup co-founded by OpenAI chairman Bret Taylor and longtime Google exec Clay Bavor, is valued at $4.5 billion after raising $175 million.
- Sierra enables businesses to automate customer support using AI.
Fundraising:
- Xaira Therapeutics: raised a $1 billion mega-round earlier this year for its AI-enabled drug discovery platform.
- Xaira Therapeutics uses AI to accelerate the discovery of new treatments and improve patient outcomes.
Topics
- Europe
- Fundraising
- Newsletter
- Startups
- United States
- Venture capital
Anna Heim is a freelance reporter at TechCrunch, exploring SaaS and more. Former LATAM & Media Editor at The Next Web, startup founder, and Sciences Po Paris alum.
Most Popular
Senator warns of national security risks after Elon Musk’s DOGE granted ‘full access’ to sensitive Treasury systems
Zack Whittaker
X expands lawsuit over advertiser ‘boycott’ to include Lego, Nestlé, Pinterest, and others
Anthony Ha
Here are all the IPOs reported to be in the works for 2025
Charles Rollet
Here are the apps battling to be become the ‘TikTok for Bluesky’
Sarah Perez
AI agents could birth the first one-person unicorn — but at what societal cost?
Paul Sawers
Elon Musk is reportedly taking control of the inner workings of US government agencies
Sean O’Kane
Sam Altman: OpenAI has been on the ‘wrong side of history’ concerning open source
Kyle Wiggers